Few Hemodialysis Patients on Medicare Enroll in Hospice
WEDNESDAY, June 27, 2018 -- Among Medicare beneficiaries on hemodialysis, few patients are enrolled in hospice at the end of life, regardless of the spending trajectory during the last year of life, according to a study published in the June issue of Health Affairs.
Ann M. O'Hare, M.D., from the University of Washington in Seattle, and colleagues examined hospice use and timing in a national cohort of Medicare beneficiaries on hemodialysis with distinct spending trajectories during their last year of life.
The researchers identified four distinct spending trajectories, which represented different intensities of care. Within the cohort, 9, 13, 41, and 37 percent had escalated spending, persistently high spending, relatively low spending with late escalation, and moderate spending with late escalation. The percentages of patients enrolled in hospice at the time of death were universally low across the groups, varying from 19 to 21 percent of those with persistently high costs and moderate costs, respectively. The median number of days spent in hospice during the last year of life was almost the same (five or six days) across the groups.
"These findings likely reflect the impact of policy and perhaps other barriers to the receipt of hospice care for patients on hemodialysis and signal the need for more flexible approaches to the provision of end-of-life care for members of this population," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: June 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.